189 related articles for article (PubMed ID: 21482636)
1. Herpes viruses and tumours in kidney transplant recipients. The role of immunosuppression.
Ponticelli C
Nephrol Dial Transplant; 2011 Jun; 26(6):1769-75. PubMed ID: 21482636
[TBL] [Abstract][Full Text] [Related]
2. Cancer incidence after immunosuppressive treatment following kidney transplantation.
Andrés A
Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
[TBL] [Abstract][Full Text] [Related]
3. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
Merlino C; Cavallo R; Bergallo M; Giacchino F; Bollero C; Negro Ponzi A; Cavallo G
New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
[TBL] [Abstract][Full Text] [Related]
4. [Skin cancer in renal transplant recipients].
Mangino M; Schena FP
G Ital Nefrol; 2010; 27 Suppl 50():S75-80. PubMed ID: 20922700
[TBL] [Abstract][Full Text] [Related]
5. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
6. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
[TBL] [Abstract][Full Text] [Related]
7. [Remission of severe disease induced by CMV and lymphoproliferative post-transplant disease after changing the immunosuppressive regime].
Gómez E; Melón S; Fresno MF; Tricas L; Navascués R; de Oña M; Herreros M; Alvarez Grande J
Nefrologia; 2002; 22(6):574-81. PubMed ID: 12516292
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
[TBL] [Abstract][Full Text] [Related]
9. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases.
Babel N; Gabdrakhmanova L; Hammer M; Rosenberger C; Oppert M; Volk HD; Reinke P
Transpl Infect Dis; 2005; 7(3-4):133-6. PubMed ID: 16390402
[TBL] [Abstract][Full Text] [Related]
10. [Herpetic viruses and renal transplantation].
Morrone LF; Capurso D; D'Elia F; Di Paolo S; Grandaliano G; Marangi AL; Schena A; Stallone G; Tarantino G;
G Ital Nefrol; 2002; 19(3):316-25. PubMed ID: 12195400
[TBL] [Abstract][Full Text] [Related]
11. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
12. Infections caused by herpes viruses other than cytomegalovirus in solid organ transplant recipients.
Carratalà J; Montejo M; Pérez-Romero P
Enferm Infecc Microbiol Clin; 2012 Mar; 30 Suppl 2():63-9. PubMed ID: 22542037
[TBL] [Abstract][Full Text] [Related]
13. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
[TBL] [Abstract][Full Text] [Related]
14. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience].
Franco A; Jiménez L; Sillero C; Trigueros M; González D; Alcaraz E; Olivares J
Nefrologia; 2010; 30(6):669-75. PubMed ID: 21113217
[TBL] [Abstract][Full Text] [Related]
15. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
16. De novo gastrointestinal tumours after renal transplantation: role of CMV and EBV viruses.
Adani GL; Baccarani U; Lorenzin D; Gropuzzo M; Tulissi P; Montanaro D; Currö G; Sainz M; Risaliti A; Bresadola V; Bresadola F
Clin Transplant; 2006; 20(4):457-60. PubMed ID: 16842521
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
18. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.
Styczynski J; Einsele H; Gil L; Ljungman P
Transpl Infect Dis; 2009 Oct; 11(5):383-92. PubMed ID: 19558376
[TBL] [Abstract][Full Text] [Related]
19. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
Leung E; Shenton BK; Green K; Jackson G; Gould FK; Yap C; Talbot D
Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
[TBL] [Abstract][Full Text] [Related]
20. Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients.
Petrisli E; Chiereghin A; Gabrielli L; Zanfi C; Lauro A; Piccirilli G; Baccolini F; Altimari A; Bagni A; Cescon M; Pinna AD; Landini MP; Lazzarotto T
Transplant Proc; 2010; 42(1):74-8. PubMed ID: 20172284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
